| 英文别名 |
5-Oxo-L-proline compd. with 1,6-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-beta-L-idopyranose (1:1);Ertugliflozin L-pyroglutamic acid;(S)-5-oxopyrrolidine-2-carboxylic acid compound with (1S,2S,3S,4R,5S)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol (1:1);1210344-83-4 (Pidolate);Ertugliflozin L-pyroglutamic Acid (1:1);Steglatro (TN);DA-73187;s4431;D80789;BS-14526;PF-4971729;ErtugliflozinL-pyroglutamicacid;ERTUGLIFLOZIN PIDOLATE [MI];CHEMBL5315054;(S)-5-oxopyrrolidine-2-carboxylic acid--(1S,2S,3S,4R,5S)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol (1/1);AKOS037648542;STEGLUJAN COMPONENT ERTUGLIFLOZIN PIDOLATE;MLU731K321;UNII-MLU731K321;(1S,2S,3S,4R,5S)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol (2S)-5-oxopyrrolidine-2-carboxylate;Ertugliflozin L-pyroglutamic Acid (1:1); L-Proline, 5-oxo-, compd. with 1,6-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-ss-L-idopyranose (1:1); 1,6-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-ss-L-idopyranose 5-oxo-L-proline; Ertuglif;AC-32016;D11043;CS-0083708;PF-4971729-00;1210344-83-4;(1S,2S,3S,4R,5S)-5-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol;(2S)-5-oxopyrrolidine-2-carboxylic acid;SEGLUROMET COMPONENT ERTUGLIFLOZIN PIDOLATE;ERTUGLIFLOZIN PIDOLATE [WHO-DD];HY-15461A;Ertugliflozin pidolate |